RPBC - Redpoint Bio Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201112/31/201012/31/2009
Total Revenue5251,244.4791,868.428
Cost of Revenue---
Gross Profit5251,244.4791,868.428
Operating Expenses
Research Development1,021.1733,041.6845,630.336
Selling General and Administrative1,937.0873,644.2064,960.913
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-2,433.26-5,441.411-8,722.821
Income from Continuing Operations
Total Other Income/Expenses Net1,617.07411.033142.04
Earnings Before Interest and Taxes-816.186-5,430.378-8,580.781
Interest Expense34.781140.751235.231
Income Before Tax-850.967-5,571.129-8,816.012
Income Tax Expense-410.726-101.306-
Minority Interest---
Net Income From Continuing Ops-440.241-5,469.823-8,816.012
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-440.241-5,469.823-8,816.012
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-440.241-5,469.823-8,816.012